RxDoctor Payments Data

Jennifer Simoneaux, MD

Family Medicine · Newburgh, INNPI 1700880036

Payments from drug & device makers

$8,252in general payments, 2019–2025

Across 575 payments — averaging $14.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • GSK$602
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$474
  • Lilly USA, LLC$354
  • Pfizer$328
  • plus $3K from 45 others

What the payments were for

  • Food & beverage$8,252100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,252 in reported general payments places this provider in the 90th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$31,825
Medicare patients
121
Services billed
362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$20,988
MounjaroTirzepatide19$19,768
EliquisApixaban16$9,546
NeuproRotigotine11$9,111
Spiriva HandihalerTiotropium Bromide13$6,857
Tresiba Flextouch U-100Insulin Degludec19$6,310
Serevent DiskusSalmeterol Xinafoate12$5,240
Arnuity ElliptaFluticasone Furoate13$2,792
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,544
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$2,262
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen85$1,818
Scopolamine13$1,184
Duloxetine Hcl42$1,055
Gabapentin70$1,053
Atorvastatin Calcium102$990

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,312$20,98817 claims
Lilly USA, LLCMounjaro$354$19,76819 claims
PfizerEliquis$328$9,54616 claims
GSKArnuity Ellipta$602$2,79213 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$12$83790 claims
AbbVieSynthroid$1,994$74811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Newburgh

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →